Genscript Biotech Corporation (FRA:G51)

Germany flag Germany · Delayed Price · Currency is EUR
1.516
+0.044 (3.02%)
Last updated: Jan 8, 2026, 8:06 AM CET
31.83%
Market Cap3.46B
Revenue (ttm)705.13M
Net Income (ttm)2.65B
Shares Outn/a
EPS (ttm)1.20
PE Ratio1.30
Forward PE37.56
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume45
Open1.516
Previous Close1.472
Day's Range1.516 - 1.516
52-Week Range1.100 - 2.042
Betan/a
RSI54.53
Earnings DateMar 10, 2026

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, pept... [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 5,568
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol G51
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.